Oklahoma Wanted $17 Billion To Fight Its Opioid Crisis: What's The Real Cost? By Christopher J. Ruhm Oklahoma Wanted $17 Billion To Fight Its Opioid Crisis: What's The Real Cost? Batten Professor of Public Policy and Economics Christopher Ruhm The state's plan — and the basis of that $17 billion ask — was looking at abatement for the next three decades. That 30-year plan was authored by Christopher Ruhm, a professor of public policy and economics at the University of Virginia. He says you can easily get into the billions when you consider the costs of dealing with this epidemic in the long term. Read Article Christopher J. Ruhm Christopher J. Ruhm (@christopherruhm) is a Professor of Public Policy & Economics at the University of Virginia. Read full bio Related Content Christopher J. Ruhm Cognitive Performance and Labour Market Outcomes Research We use the U.S. National Longitudinal Survey of Youth 1979 and other sources to examine how cognitive performance near the end of secondary schooling relates to labour market outcomes through age fifty. Our preferred estimates control for individual and family backgrounds, non-cognitive attributes, and survey years. Time Preferences and Consumer Behavior Research We investigate the predictive power of survey-elicited time preferences. The discount factor elicited from choice experiments using real payments predicts various health, energy, and financial outcomes, including overall self-reported health, smoking, installing energy-efficient lighting, and credit card balance. How Might the COVID-19 Recession Affect Your Health? An Economist Explains. News Recessions may be good for overall physical health, but this one could be different. Batten professor Chris Ruhm presented an online talk Wednesday offering an economist’s view of the overall health effects of the COVID-19 recession. His talk was the school’s third installment of its expert chat series about COVID-19. New Research: Non-Opioid Drug Death Rates Are Also on the Rise News The number of Americans dying from drug overdoses has risen rapidly in the last decade, with opioids viewed as the primary culprit. However, recent research suggests that opioids are not the only drug involved. According to Batten professor of economics, Christopher J. Ruhm, half of the overdose deaths have involved polydrug use and deaths involving nonopioid drugs are rising almost as fast as those involving opioids.